| Outgoing Relation(s) |
| specialised pro-resolving mediator (CHEBI:140399) is a anti-inflammatory agent (CHEBI:67079) |
| specialised pro-resolving mediator (CHEBI:140399) is a biological role (CHEBI:24432) |
| specialised pro-resolving mediator (CHEBI:140399) is a signalling molecule (CHEBI:62488) |
| Incoming Relation(s) |
| (10R,17S)-dihydroxy-(7Z,11E,13E,15Z,19Z)-docosapentaenoic acid (CHEBI:140265) has role specialised pro-resolving mediator (CHEBI:140399) |
| (13R,14S)-dihydroxy-(4Z,7Z,9E,11E,16Z,19Z )-docosahexaenoic acid (CHEBI:138248) has role specialised pro-resolving mediator (CHEBI:140399) |
| (7R,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid (CHEBI:138249) has role specialised pro-resolving mediator (CHEBI:140399) |
| (7S,14S)-dihydroxy-(4Z,8E,10E,12Z,16Z,19Z)-docosahexaenoic acid (CHEBI:140193) has role specialised pro-resolving mediator (CHEBI:140399) |
| (7S,8,17S)-trihydroxy-(15E,19Z)-docosa-9,11,13,15,19-pentaenoic acid (CHEBI:140271) has role specialised pro-resolving mediator (CHEBI:140399) |
| (8S)-cystein-S-yl-(7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoic acid (CHEBI:140270) has role specialised pro-resolving mediator (CHEBI:140399) |
| (8S)-glutathionyl-(7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoic acid (CHEBI:140268) has role specialised pro-resolving mediator (CHEBI:140399) |
| (8S)-glycinylcystein-S-yl-(7R,17S)-dihydroxy-(4Z,9,11,13Z,15E,19Z)-docosahexaenoic acid (CHEBI:140269) has role specialised pro-resolving mediator (CHEBI:140399) |
| 16,17(S)-dihydroxy-(7Z,10Z,13E,14E,19Z)-docosapentaenoic acid (CHEBI:140266) has role specialised pro-resolving mediator (CHEBI:140399) |
| 16(S)-cystein-S-yl,17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid (CHEBI:140264) has role specialised pro-resolving mediator (CHEBI:140399) |
| 16(S)-glutathionyl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid (CHEBI:140262) has role specialised pro-resolving mediator (CHEBI:140399) |
| 16(S)-glycinylcystein-S-yl-17(R)-hydroxy-(4Z,7Z,10,12,14,19Z)-docosahexaenoic acid (CHEBI:140263) has role specialised pro-resolving mediator (CHEBI:140399) |
| 22-hydroxyprotectin D1 (CHEBI:140243) has role specialised pro-resolving mediator (CHEBI:140399) |
| 7-Maresin 1 (CHEBI:746949) has role specialised pro-resolving mediator (CHEBI:140399) |
| 7,16,17-trihydroxy-(14E,19Z)-docosa-8,10,12,14,19-pentaenoic acid (CHEBI:140272) has role specialised pro-resolving mediator (CHEBI:140399) |
| 7,17-dihydroxy-(8Z,15E,19Z)-docosa-8,10,13,15,19-pentaenoic acid (CHEBI:140273) has role specialised pro-resolving mediator (CHEBI:140399) |
| aspirin-triggered protectin D1 (CHEBI:140202) has role specialised pro-resolving mediator (CHEBI:140399) |
| lipoxin (CHEBI:6497) has role specialised pro-resolving mediator (CHEBI:140399) |
| protectin D1 (CHEBI:138655) has role specialised pro-resolving mediator (CHEBI:140399) |
| resolvin (CHEBI:132120) has role specialised pro-resolving mediator (CHEBI:140399) |
